AI blood test could revolutionize cancer detection without invasive biopsies
NCT ID NCT06717295
Summary
This study aims to develop and validate an AI-powered blood test that can detect cancer early and monitor how well treatments are working. Researchers will analyze RNA from platelets and immune cells in blood samples from 6,000 participants, including people with various cancers and cancer-free individuals. The goal is to create a non-invasive tool that helps doctors find cancer sooner and track treatment responses more effectively.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Babraham Research Institute
ENROLLING_BY_INVITATIONCambridge, CB22 3AT, United Kingdom
-
Dysplasia Diagnostics Limited
RECRUITINGLondon, W1W 7LT, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
NSIA- Lagos University Teaching Hospital Cancer Centre
RECRUITINGLagos, Nigeria
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Email: •••••@•••••
-
Various Cancer Centres
ACTIVE_NOT_RECRUITINGRosario, Argentina
Conditions
Explore the condition pages connected to this study.